Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Should we treat the brain in glaucoma?Gupta N; Yucel YHCan J Ophthalmol 2007[Jun]; 42 (3): 409-13The loss of retinal ganglion cells in glaucoma may lead to blindness, and current therapies are directed at reducing pressure within the eye. Most of the retinal ganglion cell axon lies outside the eye, and evidence from experimental primate and human glaucoma suggests that axon injury extends from the optic nerve to visual pathways in the brain. Neurodegenerative changes in the central visual system may contribute to the pathology of glaucomatous progression. Thus, intraocular pressure-lowering strategies combined with neuroprotective therapies to protect visual neurons in the retina and brain may help to preserve vision in patients with glaucoma.|Animals[MESH]|Antihypertensive Agents/*therapeutic use[MESH]|Axons/pathology[MESH]|Blindness/prevention & control[MESH]|Geniculate Bodies/*drug effects[MESH]|Glaucoma/*drug therapy[MESH]|Humans[MESH]|Intraocular Pressure/drug effects[MESH]|Neuroprotective Agents/*therapeutic use[MESH]|Optic Nerve Diseases/*drug therapy[MESH]|Retinal Ganglion Cells/*pathology[MESH]|Visual Pathways/drug effects[MESH] |
